安大略省的ADHD兴奋剂处方从2015年的157%上升到2023年的157%,其驱动因素是提高认识和虚拟护理,特别是在妇女和青年成年人中。 ADHD stimulant prescriptions in Ontario rose 157% from 2015 to 2023, driven by increased awareness and virtual care, especially among women and young adults.

据报告,从2015年到2023年,安大略省新的ADHD刺激剂处方增加了157%,从2020年开始急剧上升。 A 157% increase in new ADHD stimulant prescriptions in Ontario from 2015 to 2023 has been reported, with a sharp rise beginning in 2020. 在18至44岁的妇女和成人中,包括10至14岁的女孩中,这种激增尤其明显,因为一些年龄组的处方率超过了男性。 The surge is particularly pronounced among women and adults aged 18 to 44, including girls aged 10 to 14, who saw prescription rates surpass those of males in some age groups. 专家将这一趋势归因于认识的提高、与大流行病有关的医疗保健机会的转变以及虚拟诊所的增长,尽管对过度诊断和潜在副作用仍然感到关切。 Experts attribute the trend to greater awareness, pandemic-related shifts in healthcare access, and the growth of virtual clinics, though concerns remain about overdiagnosis and potential side effects.